<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00153114</url>
  </required_header>
  <id_info>
    <org_study_id>851-15</org_study_id>
    <nct_id>NCT00153114</nct_id>
  </id_info>
  <brief_title>PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children</brief_title>
  <official_title>PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Braintree Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Braintree Laboratories</source>
  <brief_summary>
    <textblock>
      Assess the safety and efficacy of polyethyleneglycol3350 laxative as compared to placebo
      therapy in pediatric patients with a history of constipation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <primary_completion_date type="Actual">September 2004</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Greater than 2 bowel movements per week</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of individual ROME I criteria</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety (adverse event and laboratory testing)</measure>
  </secondary_outcome>
  <enrollment>100</enrollment>
  <condition>Constipation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>polyethyleneglycol3350</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female outpatients between the ages of 4 to 16 years.

          -  Adolescent female patients must not be pregnant or lactating.

          -  constipated according to ROME I definition

          -  Two or fewer bowel movements during the initial observation week.

          -  Absence of a stool impaction

          -  Bowel movement after receiving enema

          -  Are otherwise in good health, as judged by a physical examination.

          -  Parent or guardian is mentally competent to sign an instrument of informed consent

        Exclusion Criteria:

          -  Patients with heme positive stool at baseline exam.

          -  Patients with fecal impaction at baseline, or after the observation period, as
             indicated by physical exam

          -  Patients with known or suspected perforation or obstruction other than fecal
             impaction.

          -  Patients who are breastfeeding, pregnant or intend to become pregnant during the
             study.

          -  Female patients of childbearing potential who refuse a pregnancy test.

          -  Patients with a known history of organic cause for their constipation.

          -  Patients with congenital malformations that produce constipation (Hirschsprung's
             disease, imperforate anus, children with cerebral palsy or other neurologic
             abnormalities, or systemic diseases).

          -  History of gastric retention, inflammatory bowel disease, bowel resection, or
             colostomy.

          -  Use of concomitant medications that cause constipation

          -  Patients who, in the opinion of the investigator, should not be included in the study
             for any reason, including inability to follow study procedures.

          -  Patients with known allergy to polyethyleneglycol or polyethyleneglycol containing
             medications.

          -  Patients with clinically significant elevations of TSH or abnormal plasma
             electrolytes.

          -  Patients who, within the past 30 days have participated in an investigational clinical
             study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Samuel Nurko, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Childrenâ€™s Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07962</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2005</study_first_submitted>
  <study_first_submitted_qc>September 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>February 6, 2013</last_update_submitted>
  <last_update_submitted_qc>February 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2013</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Laxatives</mesh_term>
    <mesh_term>Polyethylene glycol 3350</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

